Alcohol Withdrawal
40
4
4
20
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
7.5%
3 terminated out of 40 trials
87.0%
+0.4% vs benchmark
13%
5 trials in Phase 3/4
40%
8 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 20 completed trials
Clinical Trials (40)
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
Study of Exploratory Plasmatic Markers of Alcohol Withdrawal
Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients
Use of tAN® in Alcohol Withdrawal Management
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
Osteopathic Treatment to Alcohol Withdrawal Syndrome
Remote Treatment of Alcohol Withdrawal
Comparison of the Effect on Anxiety of Combining Hypnosis and Aromatherapy Through Olfactory Anchoring Versus Standard Care in Patients Undergoing Alcohol Withdrawal
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
NCARE, Transition to Recovery
Bright Light Therapy During Residential Alcohol Withdrawal
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
Family Based Prevention of Alcohol and Risky Sex for Older Teens
Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in France
Digitally Assisted Recovery Coach